Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
The Most Astonishing Arising Advancements to Watch - 26 Arranging Administrations to Change Your Open air Space
- 3Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025
- 4From invasive species tracking to water security – what’s lost with federal funding cuts at US Climate Adaptation Science Centers
- 5CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
- Dental Embed Developments: Upsetting Current Dentistry
- Bonk.fun’s April Fools Joke Targets Israel, Sparks Debate
- Potential Houthi threat to Red Sea shipping could further damage global economy
- Eleven Creations And Developments That Steered History
- Collection of 7,000-year-old ostrich eggs discovered under sand dunes in southern Israel
- The Best Internet based Courses for Expertise Improvement
- 6 Pet Sitting Administrations for Your Cherished Pets
- Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.
- Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
